SPONSOR
The First Affiliated Hospital of Soochow University
Total Trials
17
Recruiting
17
Phases
Phase 2, Phase 1, EARLY_Phase 1, Phase 2, Phase 3
Conditions studied: Prostate CancerProstate Cancer (Diagnosis)Irritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea (IBS-D)Repetitive Transcranial Magnetic Stimulation (rTMS)Chronic DiarrheaIntestinal FloraDLBCL - Diffuse Large B Cell LymphomaAcute LeukemiaKMT2A Rearrangements or NPM1 Mutations Acute Leukemia
The First Affiliated Hospital of Soochow University is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Prostate Cancer, Prostate Cancer (Diagnosis), Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D).
The trial portfolio spans Phase 2, Phase 1, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Affiliated Hospital of Soochow University
How many clinical trials has The First Affiliated Hospital of Soochow University sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by The First Affiliated Hospital of Soochow University, of which 17 are actively recruiting participants. These trials cover conditions including Prostate Cancer, Prostate Cancer (Diagnosis), Irritable Bowel Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Affiliated Hospital of Soochow University research focus on?
The First Affiliated Hospital of Soochow University clinical trials span Prostate Cancer, Prostate Cancer (Diagnosis), Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), and additional conditions. The research pipeline includes Phase 2, Phase 1, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The First Affiliated Hospital of Soochow University clinical trial?
To participate in a The First Affiliated Hospital of Soochow University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Affiliated Hospital of Soochow University trials with current recruitment status updated daily.
Clinical Trials by The First Affiliated Hospital of Soochow University
NCT07552285
Recruiting
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
Prostate Cancer
NCT07581756
Recruiting
Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial
Irritable Bowel Syndrome
NCT07255963 Phase 2
Recruiting
Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
DLBCL - Diffuse Large B Cell Lymphoma
NCT07270770 Phase 1
Recruiting
BY002 IIT Study in R/R Acute Leukemia
Acute Leukemia
NCT07074496 EARLY_Phase 1
Recruiting
Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NCT05571774
Recruiting
Construction of a Database for TTP
TTP - Thrombotic Thrombocytopenic Purpura
NCT06682416
Recruiting
The Impact of Local Anesthetic Solution Temperature on Epidural-related Maternal Fever
Epidural Related Maternal Fever
NCT04745221
Recruiting
Efficacy and Safety of Auto-FMT in Preventing aGVHD
Graft Versus Host Disease, Acute
NCT05657652
Recruiting
CAV Regimen for R/R Ph- B-ALL
Acute Lymphoblastic Leukemia
NCT05521204 Phase 2
Recruiting
Olverembatinib for FGFR1-rearranged Neoplasms
Myeloproliferative Neoplasm
NCT06682130 Phase 2
Recruiting
Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL
Diffuse Large B-cell Lymphoma(DLBCL)
NCT07074470
Recruiting
Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
Primary Central Nervous System Lymphoma (PCNSL)
NCT07159620 Phase 2
Recruiting
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Adult T-cell Leukemia/Lymphoma
NCT06393985 Phase 2
Recruiting
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
B-cell Acute Lymphoblastic Leukemia
NCT06985485 Phase 2
Recruiting
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
Acute Lymphoblastic Leukemia
NCT07562542
Recruiting
Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
Systemic Mastocytosis
NCT05404906 Phase 2, Phase 3
Recruiting
AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission
Acute Myeloid Leukemia (AML) in Remission
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology